A detailed history of Apella Capital, LLC transactions in Danaher Corp stock. As of the latest transaction made, Apella Capital, LLC holds 2,004 shares of DHR stock, worth $467,132. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,004
Previous 1,977 1.37%
Holding current value
$467,132
Previous $493,000 12.98%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$239.25 - $280.76 $6,459 - $7,580
27 Added 1.37%
2,004 $557,000
Q2 2024

Jul 10, 2024

SELL
$235.51 - $267.98 $3,532 - $4,019
-15 Reduced 0.75%
1,977 $493,000
Q1 2024

Apr 10, 2024

BUY
$224.58 - $256.19 $4,940 - $5,636
22 Added 1.12%
1,992 $497,000
Q4 2023

Jan 05, 2024

SELL
$185.1 - $233.13 $67,006 - $84,393
-362 Reduced 15.52%
1,970 $455,000
Q3 2023

Oct 10, 2023

BUY
$233.08 - $265.59 $10,721 - $12,217
46 Added 2.01%
2,332 $578,000
Q2 2023

Jul 06, 2023

BUY
$224.99 - $256.14 $42,523 - $48,410
189 Added 9.01%
2,286 $548,000
Q4 2022

Jan 10, 2023

BUY
$241.42 - $282.29 $12,071 - $14,114
50 Added 2.44%
2,097 $0
Q3 2022

Oct 11, 2022

BUY
$247.06 - $1507.4 $15,070 - $91,951
61 Added 3.07%
2,047 $529,000
Q2 2022

Jul 08, 2022

SELL
$237.11 - $299.66 $648,258 - $819,270
-2,734 Reduced 57.92%
1,986 $503,000
Q1 2022

Apr 11, 2022

BUY
$257.27 - $315.76 $160,021 - $196,402
622 Added 15.18%
4,720 $1.38 Million
Q4 2021

Jan 13, 2022

SELL
$292.08 - $329.01 $202,703 - $228,332
-694 Reduced 14.48%
4,098 $1.35 Million
Q3 2021

Jan 18, 2022

BUY
$272.21 - $332.43 $1.3 Million - $1.59 Million
4,792 New
4,792 $1.46 Million
Q3 2021

Oct 12, 2021

SELL
$272.21 - $332.43 $1.13 Million - $1.39 Million
-4,168 Closed
0 $0
Q2 2021

Jan 18, 2022

BUY
$225.08 - $271.69 $938,133 - $1.13 Million
4,168 New
4,168 $1.12 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $170B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Apella Capital, LLC Portfolio

Follow Apella Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apella Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apella Capital, LLC with notifications on news.